<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14994">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01960608</url>
  </required_header>
  <id_info>
    <org_study_id>24UNainCKD</org_study_id>
    <nct_id>NCT01960608</nct_id>
  </id_info>
  <brief_title>The Analysis of Correlation About the 24hours Urine Sodium and the Blood Pressure in Patient With CKD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      There was no difference of the amount of 24 hour urine sodium between non-Chronic Kidney
      Disease and Chronic kidney disease. We found that the 24 urine sodium was usable for
      estimating the amount of salt intake in patient with chronic kidney disease and to take the
      amount of sodium over 80 milliequivalent per liter was associated with the higher blood
      pressure.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>24 hour urine sodium and the degree of control of blood pressure in chronic kidney disease</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>low sodium group</arm_group_label>
    <description>24_hours_urine_sodium &lt; 100 mEq/L</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mid sodium group</arm_group_label>
    <description>24_hours_urine_sodium &gt;= 100 mEq/L and &lt; 200 mEq/L</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high sodium group</arm_group_label>
    <description>24_hours_urine_sodium &gt;= 200 mEq/L</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>24_hours_urine_sodium</intervention_name>
    <arm_group_label>low sodium group</arm_group_label>
    <arm_group_label>mid sodium group</arm_group_label>
    <arm_group_label>high sodium group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        chronic kidney disase
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all the patient who have the result of 24 hours urine sodium and creatinine

        Exclusion Criteria:

          -  no pregnancy

          -  malignancy

          -  who have taking diuretics ( all kinds )
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>hoseok koo</last_name>
    <phone>82222700555</phone>
    <email>hoseok.koo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inje University Seoul Paik Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>100-032</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jin Park</last_name>
      <phone>02-2270-0945</phone>
      <email>jinni826@daum.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 9, 2013</lastchanged_date>
  <firstreceived_date>October 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Hoseok Koo</investigator_full_name>
    <investigator_title>Assisted professior</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
